MET and breast cancer: In addition, abnormal c-MET expression in several carcinomas, including breast cancer, cervical cancer, gastric cancer, and colorectal cancer, produces several signaling cascades and is associated with enhanced proliferation, blocking apoptosis, and poor prognosis [22,23,24,25].